Researchers at MIT’s David H. Koch Institute for Integrative Cancer Research, in collaboration with the Harvard Stem Cell Institute (HSCI) and several other institutions have developed a technology that promises imminent cure for diabetes first.

This is a very complex bio-engineering work which is the essence of producing cells for the production of insulin in the body, which are developed from stem cells. The results are presented to the public after eight years of dedicated work.

It is a very important step forward, which shows that there is a possibility soon overcomes the problems in the treatment of type 1 diabetes, is considered one of the directors of the HSCI-ROM Doug Melton.

Key step in what is shown in animal models to a new way of “insertion” in mammalian cells have at least 6-8 months to show biocompatible, without causing a so-called. It is expected that could soon begin clinical trials.

Type 1 diabetes is a very unpleasant autoimmune disease in which the immune system kills the pancreatic beta cells that produce insulin. For now, the best treatment that is offered is medical injection daily dose of insulin. The consequences of type 1 diabetes are in many cases very severe; tend to cause blindness, heart disease and death.

It is expected that the improvement in treatments for something less dangerous diabetes type 2 which in many countries takes on epidemic proportions.